Published in J Virol Methods on January 01, 1991
An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol (2000) 4.00
Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J Clin Microbiol (1993) 1.78
Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection. Clin Exp Immunol (1994) 1.46
Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load. Clin Diagn Lab Immunol (1998) 1.19
Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J Clin Microbiol (1994) 1.01
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661. Proc Natl Acad Sci U S A (1993) 0.94
Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH. J Clin Microbiol (1993) 0.88
Stability of free and complexed human immunodeficiency virus type 1 antigen at 4 degrees C and at room temperature. J Clin Microbiol (1995) 0.87
Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol (1995) 0.84
Detection of Acute and Early HIV-1 Infections in an HIV Hyper-Endemic Area with Limited Resources. PLoS One (2016) 0.83
Impact of heat treatment on antigen detection in sera of Angiostrongylus vasorum infected dogs. Parasit Vectors (2017) 0.75
Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS (1993) 3.52
Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet (1977) 2.65
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48
Hemorrhagic fever with renal syndrome. Prog Med Virol (1989) 2.38
Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol (1994) 2.29
Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee. Virology (1996) 1.91
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet (1985) 1.85
Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J Clin Microbiol (1994) 1.81
Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J Virol (1998) 1.75
Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia. J Med Virol (1992) 1.73
Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides. Clin Chem (1991) 1.73
Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS (1992) 1.72
Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis (2000) 1.52
Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol (1999) 1.51
Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection. Clin Exp Immunol (1994) 1.46
Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol (1996) 1.41
Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Clin Exp Immunol (1995) 1.40
Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull World Health Organ (1991) 1.40
Sensitivity of HIV-antibody assays determined by seroconversion panels. AIDS (1994) 1.37
Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes (1994) 1.32
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31
Ebola virus virulence for newborn mice. J Med Virol (1979) 1.26
Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses (1994) 1.25
Ecological and epidemiological data on Hantavirus in bank vole populations in Belgium. Arch Virol (1986) 1.24
Phylogenetic analysis of a new chimpanzee lentivirus SIVcpz-gab2 from a wild-captured chimpanzee from Gabon. AIDS Res Hum Retroviruses (1994) 1.21
What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS (1999) 1.18
Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet (1996) 1.17
A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams. J Infect Dis (1999) 1.17
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol (1991) 1.15
Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS (1998) 1.14
Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire. Lancet (1992) 1.11
Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses (1995) 1.10
Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods (1997) 1.08
Isolation of HIV-1 RNA from plasma: evaluation of seven different methods for extraction (part two). J Virol Methods (1998) 1.08
A look at the P4 virus containment laboratory. Prog Med Virol (1982) 1.07
Risk factors for infection with human immmunodeficiency virus among European expatriates in Africa. BMJ (1988) 1.05
Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera. Eur J Clin Microbiol (1987) 1.04
Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J Clin Microbiol (1994) 1.01
Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. AIDS (1993) 1.00
Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS (2000) 1.00
Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material. Lancet (1983) 1.00
Replication of arboviruses in mouse organ cultures. II. Multiplication of virulent and avirulent Semliki Forest and western equine encephalitis viruses in mouse organ cultures. Arch Virol (1975) 0.99
Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS (1994) 0.98
Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies. Sex Transm Dis (1994) 0.97
HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS (2001) 0.97
Interaction of mouse peritoneal macrophages with different arboviruses in vitro. J Gen Virol (1977) 0.97
Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods (1998) 0.95
Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees. AIDS (2001) 0.95
Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods. J Virol Methods (1996) 0.95
Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.95
Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells. Virology (2001) 0.94
Comparison of immunofluorescence and enzyme-linked immunosorbent assays for the serology of Hantaan virus infections. J Virol Methods (1989) 0.93
Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res Hum Retroviruses (2000) 0.93
Light and electron microscope studies on extravascular Trypanosoma brucei gambiense in the brain of chronically infected rodents. Ann Soc Belg Med Trop (1981) 0.93
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses (2000) 0.92
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS (1996) 0.90
Design and production of a target-specific monoclonal antibody to parvovirus B19 capsid proteins. J Immunol Methods (1995) 0.89
Effect of partial portal vein ligation on immune glomerular deposits in Schistosoma mansoni-infected mice. Br J Exp Pathol (1977) 0.89
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS (1998) 0.89
Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol (1997) 0.89
Evaluation of immunofluorescence and immunoperoxidase methods for antibody determination against Chikungunya, West Nile and yellow fever viruses. Ann Soc Belg Med Trop (1979) 0.89
Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire. Br Med J (Clin Res Ed) (1985) 0.89
Different hantavirus serotypes in western Europe. Lancet (1991) 0.88
Kaposi's sarcoma in Zaire is not associated with HTLV-III infection. N Engl J Med (1984) 0.88
Endemic African Kaposi's sarcoma is not associated with immunodeficiency. Int J Cancer (1985) 0.88
Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. AIDS Res Hum Retroviruses (1999) 0.88
Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Infect Dis (1995) 0.87
Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS (1998) 0.87
Isolation in Vero-E6 cells of Hanta virus from Clethrionomys glareolus captured in the Bashkiria area of the U.S.S.R. Ann Soc Belg Med Trop (1984) 0.87
Genetic characterization of Puumala hantavirus strains from Belgium: evidence for a distinct phylogenetic lineage. Virus Res (2001) 0.87
HIV-1 genetic variability in Cameroon. AIDS (2000) 0.86
Haemorrhagic fever with renal syndrome: evaluation of ELISA for detection of Puumala-virus-specific IgG and IgM. Res Virol (1991) 0.86
Immunological comparison of HIV-1-, HIV-2- and dually-reactive women delivering in Abidjan, Côte d'Ivoire. AIDS (1992) 0.86
Interpatient genetic variability of HIV-1 group O. AIDS (1999) 0.86
Role of IgM-rheumatoid factor interference in the determination of total serum IgE and IgE-containing circulating immune complexes. Clin Exp Immunol (1988) 0.86
Evaluation and comparison of the Amplicor HIV-1 PCR kit with an 'in-house' nested PCR. Clin Diagn Virol (1995) 0.85
Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands. Virology (2000) 0.85
Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America. Virology (2000) 0.85
Enzyme immuno assay for the detection of virus specific IgG and IgM antibody in patients with haemorrhagic fever with renal syndrome. Arch Virol (1988) 0.84
Serological detection of infection with diverse human and simian immunodeficiency viruses using consensus env peptides. Clin Diagn Lab Immunol (2000) 0.84
The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them. AIDS Res Hum Retroviruses (1997) 0.84
Reanalysis of full-length HIV type 1 group M subtype K and sub-subtype F2 with an MS-DOS bootscanning program. AIDS Res Hum Retroviruses (2001) 0.84
Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees. J Med Primatol (2001) 0.84
Partial characterization of a Hantavirus isolated from a Clethrionomys glareolus captured in Belgium. Acta Virol (1987) 0.83
[Cancer incidence in the hospital of Katana, Kivu, East Zaire, 1983-1986]. Ann Soc Belg Med Trop (1988) 0.83
HIV type 1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses (1998) 0.83
Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally. J Med Virol (2001) 0.83
Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis. Arch Dis Child (1988) 0.83
Hemorrhagic fever with renal syndrome in a Canadian serviceman. CMAJ (1990) 0.82
HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5. Int J Cancer (1987) 0.82
Evaluation of an agglutination HIV-1 + 2 antibody assay. J Virol Methods (1995) 0.81
How many different HIV-1 viral load test kits do we need? AIDS (1998) 0.81
Development of a one-tube multiplex reverse transcriptase-polymerase chain reaction assay for the simultaneous amplification of HIV type 1 group M gag and env heteroduplex mobility assay fragments. AIDS Res Hum Retroviruses (2000) 0.81
Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O. AIDS Res Hum Retroviruses (2000) 0.81
Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones. AIDS (2000) 0.81